In this podcast, James chats to John Myburgh about IV fluids. IV fluids are an integral part of therapy for patients in the hospital but come with some adverse effects, toxicities and potential complications.
Script Writer: Sam Orton
Interviewee: John Myburgh
Summary Writer: Lise Kempler
Reviewer: John Myburgh and Luke Collett
Professor John Myburgh is Professor of Critical Care at the Faculty of Medicine, University of New South Wales; Director of the Division of Critical Care and Trauma at the George Institute for International Health and senior intensive care physician at the St George Hospital, Sydney.
He also holds honorary professorial appointments at the University of Sydney and Monash University School of Public Health.
Professor Myburgh was a foundation member and past Chairman of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. He has an extensive research record of accomplishment over 25 years.
Professor Myburgh is regarded as a national and international expert in:
He also has expertise from the development and co-ordination of over 40 studies in Intensive Care Medicine. He has been awarded over $75M in cumulative research funding from national and international research funding agencies.
His list of publications includes over 230 refereed research publications and 45 book chapters, with an h-index of 41. He has delivered over 400 presentations. This includes over 50 plenary presentations at major international and national scientific congresses.
Professor Myburgh has a long-established profile in education in Intensive Care Medicine, both at undergraduate and postgraduate levels. He was instrumental in establishing the College of Intensive Care Medicine of Australia and New Zealand. Furthermore, he served as its President from 2010-2012. In 2014, he was made an Officer of the Order of Australia for services to medicine.
In 2013, Professor Myburgh was elected to the WFSICCM Council. He was elected as Secretary-General in November 2017 and will hold this office until 2019.
With Professor John Myburgh, Intensivist at St George Hospital and Professor of Intensive Care Medicine at The University of New South Wales, Australia
Introduction
Intravenous (IV) fluids are an integral part of therapy in the hospital. In the context of hypovolaemia, IV fluids are life-saving. However, the decision to prescribe fluids is not one to be made lightly. The adverse effects, toxicities and complications of IV fluids need to be considered every time they are administered. Unless a patient is truly clinically hypovolaemic, the question should arise whether fluids need to be given at all.
You are working in the Emergency Department and you have been called into the Resuscitation Bay by the registrar to help with a 65-year-old gentleman, who is septic from a presumed urinary source. HR 140 and BP 90/60. He is confused and warm to the touch.
On your night shift, the nursing staff on the wards call you at 3 AM as they are concerned about a 65-year-old female, who is day 1 post-hemicolectomy. Her urine output has dropped to 20 ml/hr and they are asking you to please fill out a fluid order.
If you enjoyed listening to this week’s podcast feel free to let us know what you think by posting your comments or suggestions in the comments box below.
If you want to listen to this episode while not connected to WiFi or the internet, you can download it. To find out more go to Apple support (https://support.apple.com/en-us/HT201859)